Special Report
1490 Articles
When Gallup asked people about the state of the economy this spring, as a recovery appeared to have taken hold,…
Online drug research firm drugs.com today released its list of the top 100 selling drugs in the United States for…
Abbott Laboratories (NYSE: ABT) reported second-quarter results this morning that beat the consensus estimate for earnings per share (EPS), but…
What usually happens when you get two mergers announced in drugs and biotech in the same day? Investors begin to…
More biotech mergers are on the way! That is the verdict of Wall St. There may be patent protection risks…
Some mergers are very straight-forward, and others are just odd. Now we have an answer over whether or not Amylin…
Some products sell well when first introduced. Many more fail miserably. Very few of them sell so well that they…
Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) is back in the rumor mill as far as a buyout, but this time the…
China’s PMI indicates a considerable slowing of its economy. (Reuters) Senior EC and ECB officials warn that the eurozone is on…
The 10-year Treasury hit yet another record low under 1.6% today and stocks are in the tank again due to…
A stock market that sells off eight of nine days is not a good market. Even the Facebook IPO is…
The energy sector saw a lot of activity from short sellers in April, but other stocks saw some action as…
Sony (NYSE: SNE) says it will return to profit and will cut its TV unit losses in half. (Reuters) Cisco…
Blame whatever you want. A weaker U.S. economy, a weakening and flailing Europe, a move to socialism in France and…
Moody’s warns that Japan’s finances will be hurt if it cannot get acceptance of a new sales tax. (Reuters) New…
Our top personal finance-related articles today. Your wallet will thank you later.